Annual Shareholders Equity
-$99.63 M
-$24.32 M-32.30%
December 1, 2023
Summary
- As of February 7, 2025, ACTU annual stockholders equity is -$99.63 million, with the most recent change of -$24.32 million (-32.30%) on December 1, 2023.
- During the last 3 years, ACTU annual shareholders equity has fallen by -$24.32 million (-32.30%).
- ACTU annual shareholders equity is now -32.30% below its all-time high of -$75.31 million, reached on December 1, 2022.
Performance
ACTU Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$5.36 M
+$119.62 M+104.69%
September 1, 2024
Summary
- As of February 7, 2025, ACTU quarterly stockholders equity is $5.36 million, with the most recent change of +$119.62 million (+104.69%) on September 1, 2024.
- Over the past year, ACTU quarterly shareholders equity has increased by +$119.62 million (+104.69%).
- ACTU quarterly shareholders equity is now at all-time high.
Performance
ACTU Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ACTU Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.3% | +104.7% |
| 3 y3 years | -32.3% | +104.7% |
| 5 y5 years | -32.3% | +104.7% |
ACTU Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.3% | at low | at high | +104.7% |
| 5 y | 5-year | -32.3% | at low | at high | +104.7% |
| alltime | all time | -32.3% | at low | at high | +104.7% |
Actuate Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.36 M(-104.7%) |
| Jun 2024 | - | -$114.26 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -$107.77 M(+8.2%) |
| Dec 2023 | -$99.63 M(+32.3%) | -$99.63 M |
| Dec 2022 | -$75.31 M | - |
FAQ
- What is Actuate Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Actuate Therapeutics?
- What is Actuate Therapeutics annual shareholders equity year-on-year change?
- What is Actuate Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly shareholders equity year-on-year change?
What is Actuate Therapeutics annual stockholders equity?
The current annual shareholders equity of ACTU is -$99.63 M
What is the all time high annual shareholders equity for Actuate Therapeutics?
Actuate Therapeutics all-time high annual stockholders equity is -$75.31 M
What is Actuate Therapeutics annual shareholders equity year-on-year change?
Over the past year, ACTU annual stockholders equity has changed by -$24.32 M (-32.30%)
What is Actuate Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ACTU is $5.36 M
What is the all time high quarterly shareholders equity for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly stockholders equity is $5.36 M
What is Actuate Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ACTU quarterly stockholders equity has changed by +$119.62 M (+104.69%)